Epivax, Inc.
Records under this name other than the patents Epivax, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 9 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,188,710 | Novel Regulatory T Cell Epitope and Hepatitis C Virus Homolog Formerly held In force · High confidence | In force | High confidence | |
| US 12,275,956 | Regulatory T Cell Epitopes Formerly held In force · High confidence | In force | High confidence | |
| US 11,690,902 | Coxiella Burnetii Epitopes for T Cell-Targeted Q Fever Vaccines Formerly held In force · High confidence | In force | High confidence | |
| US 11,441,122 | Regulatory T Cell Epitopes Formerly held In force · High confidence | In force | High confidence | |
| US 11,045,528 | Regulatory T Cell Epitopes, Compositions and Uses Thereof Lapsed on the fee record Ended Jun 29, 2025 · High confidence | Lapsed on the fee record | Ended Jun 29, 2025 | High confidence |
| US 11,045,529 | Regulatory T Cell Epitopes, Compositions and Uses Thereof Lapsed on the fee record Ended Jun 29, 2025 · High confidence | Lapsed on the fee record | Ended Jun 29, 2025 | High confidence |
| US 11,045,530 | Regulatory T Cell Epitopes, Compositions and Uses Thereof Lapsed on the fee record Ended Jun 29, 2025 · High confidence | Lapsed on the fee record | Ended Jun 29, 2025 | High confidence |
| US 11,045,531 | Regulatory T Cell Epitopes, Compositions and Uses Thereof Lapsed on the fee record Ended Jun 29, 2025 · High confidence | Lapsed on the fee record | Ended Jun 29, 2025 | High confidence |
| US 11,045,532 | Regulatory T Cell Epitopes, Compositions and Uses Thereof Lapsed on the fee record Ended Jun 29, 2025 · High confidence | Lapsed on the fee record | Ended Jun 29, 2025 | High confidence |
| US 10,980,867 | Regulatory T Cell Epitopes, Compositions and Uses Thereof Lapsed on the fee record Ended Apr 20, 2025 · High confidence | Lapsed on the fee record | Ended Apr 20, 2025 | High confidence |